Dudediligence.

NovaBridge Biosciences

NBPNASDAQ
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

265.4M

on 2025-12-31 10-Q ↗

a raise that quarter, at its price

100M200MDec2025

Newest

$250.0M

F-3 of 2025-05-02. 1 prospectus supplement filed under it since. F-3 ↗

$50.0M

Leerink Partners, agreement of 2025-05-02. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

No warrant count read from a 10-Q or 10-K.

Cash

Four quarters of operating cash flow to 2025-12-31 are not all on file.

Raised
DateWhatSharesPriceGrossFiling
2025-08-01Public offering33,333,330$1.95$65.0M424B5 ↗